BioFront Therapeutics
BioFront Therapeutics

BioFront Therapeutics Email Formats

Contact top employees from BioFront Therapeutics
  • BioFront Therapeutics uses 6 formats total. Most emails use firstName.lastNameInitial: jane.d@biofronttherapeutics.com. This shows up in about 66% of work addresses.
  • Other common patterns:
    • lastNameInitial-firstNameInitial → d-j@biofronttherapeutics.com
    • firstNameInitial-lastNameInitial → j-d@biofronttherapeutics.com

Popular BioFront Therapeutics's Email Templates

BioFront Therapeutics ’s Employees Email Address FormatsPercentage

Employees Email Address Formats

firstName.lastNameInitial
jane.d@biofronttherapeutics.comPercentage: 66%

Employees Email Address Formats

firstNameInitial-lastNameInitial
j-d@biofronttherapeutics.comPercentage: 12%

Employees Email Address Formats

lastNameInitial-firstNameInitial
d-j@biofronttherapeutics.comPercentage: 8%

Employees Email Address Formats

firstNameInitial_lastNameInitial
j_d@biofronttherapeutics.comPercentage: 7%

Employees Email Address Formats

firstNameInitial-lastName
j-doe@biofronttherapeutics.comPercentage: 6%

Employees Email Address Formats

lastNamefirstName
doejane@biofronttherapeutics.comPercentage: 1%
Contact top employees from BioFront Therapeutics
Tianwei Ma
Vice President, Head Of Chemistry
View
Bei Shan
Founder and CEO
View
Nancy Yang
Senior Manager, Lab Operations
View
Hui Zhang
Principle Scientist-Director of Biology
View
Wei Xue
Director of Drug Discovery, Immunoncology Project Lead
View
Christine Huang
Human Resources Director
View

Data Privacy

GDPR Icon

GDPR COMPLIANT

SignalHire complies with the General Data Protection Regulation (GDPR). SignalHire follows GDPR requirements, including but not limited to rights of data subjects to access, correct, or delete their personal information and supports the right to be forgotten.

CCPA Icon

CCPA COMPLIANT

SignalHire is CCPA-compliant and provides California residents the right to know, access, opt out, and request deletion of their personal data.

BACK TO TOP